Denosumab (Prolia): Clinical Trials

2 trials of Denosumab (Prolia), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Not yet recruiting 1

Follow Denosumab (Prolia): new trials by email Literature Review of Denosumab (Prolia) trials Research Report on Denosumab (Prolia)

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RANKL Inhibition to Combat Sarcopenia in Hip Fracture Patients
Denosumab (Prolia), Zoledronic acide (Aclasta) - Sarcopenia in Elderly
Phase 3Not yet recruitingPrince of Wales Hospital, Shatin, Hong Kong1302027-01-012026-09-16
Denosumab for Prevention of Osteoporosis in Renal Transplant Recipients
Denosumab (Prolia) - Osteoporosis, Chronic Kidney Disease
Phase 3CompletedRudolf Wuethrich902011-06-012016-05-26

Conditions studied

Bone Diseases, Metabolic (1)  ·  Osteoporosis (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

Prince of Wales Hospital, Shatin, Hong Kong (1)  ·  Rudolf Wuethrich (1)

Countries

China (1)  ·  Switzerland (1)

Top investigators

Rudolf P Wuthrich, MD (1)

Results publications

PMID 26713403, PMID 39382091